Literature DB >> 12578872

Detecting occult coronary disease in a high-risk asymptomatic population.

Roger S Blumenthal1, Diane M Becker, Lisa R Yanek, Thomas R Aversano, Taryn F Moy, Brian G Kral, Lewis C Becker.   

Abstract

BACKGROUND: Exercise stress testing alone or with perfusion imaging is the standard screening method to determine the presence of obstructive coronary artery disease (CAD) in people with chest pain. In asymptomatic individuals with a family history of premature CAD, it is unclear whether abnormalities on these functional exercise tests represent significant coronary disease. METHODS AND
RESULTS: An abnormal exercise test, thallium scan, or both occurred in 153 (21%) of 734 asymptomatic siblings of persons with documented CAD, of whom 105 underwent coronary angiography with quantitative analysis of stenosis severity. Overall, 95% had coronary atherosclerosis, but only 39% had 1 or more stenoses with >or=50% narrowing. Of 30 siblings in whom the exercise test and perfusion scan were both abnormal, 70% had >or=50% stenoses. The mean stenosis in arteries that fed perfusion defects was only 43+/-31%, and 68% of such stenoses were <50%. However, in 71% of all defects, the location matched arteries with the most severe stenoses.
CONCLUSIONS: In asymptomatic persons with a family history of CAD, abnormal exercise scintigraphy identifies predominantly mild coronary atherosclerosis. Perfusion defects may be caused by coronary vasomotor dysfunction in addition to atherosclerotic plaque.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12578872     DOI: 10.1161/01.cir.0000048127.93169.88

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Screening asymptomatic low-risk individuals for coronary heart disease: issues and controversies.

Authors:  Leslee J Shaw; Roger S Blumenthal; Paolo Raggi
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

Review 2.  Role of noninvasive imaging in asymptomatic high-risk patients.

Authors:  Leslee J Shaw; Allen Taylor; Paolo Raggi; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Monitoring effectiveness of medical therapy in 2006.

Authors:  Ronald G Schwartz; Mark A Kudes
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 4.  Epidemiologic guidance with coronary artery calcium scoring.

Authors:  Paolo Raggi; Leslee J Shaw
Journal:  Curr Cardiol Rep       Date:  2008-02       Impact factor: 2.931

Review 5.  Silent myocardial ischemia: recent developments.

Authors:  Peter F Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

6.  Severity of inducible myocardial ischemia predicts incident acute coronary syndromes in asymptomatic individuals with a family history of premature coronary artery disease.

Authors:  Brian G Kral; Diane M Becker; Dhananjay Vaidya; Lisa R Yanek; Lewis C Becker
Journal:  J Nucl Cardiol       Date:  2011-11-12       Impact factor: 5.952

7.  Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins.

Authors:  Viola Vaccarino; Durreshahwar Khan; John Votaw; Tracy Faber; Emir Veledar; Dean P Jones; Jack Goldberg; Paolo Raggi; Arshed A Quyyumi; J Douglas Bremner
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

8.  Silent small-vessel cerebrovascular disease and silent myocardial ischemia in families with premature coronary disease.

Authors:  Paul A Nyquist; Robert Wityk; Lisa R Yanek; Dhananjay Vaidya; David M Yousem; Lewis C Becker; Diane M Becker
Journal:  Neuroepidemiology       Date:  2009-04-28       Impact factor: 3.282

9.  Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy.

Authors:  John O Prior; David Monbaron; Melanie Koehli; Maria-Lucia Calcagni; Juan Ruiz; Angelika Bischof Delaloye
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-10       Impact factor: 9.236

Review 10.  Noninvasive monitoring of medical therapy.

Authors:  Mark A Kudes; Ronald G Schwartz
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.